Mechanisms of enhancer regulation in aging and age-related diseases

衰老和年龄相关疾病的增强子调节机制

• 批准号: 9977548
• 负责人: Lu Wang
• 金额: $ 9.94万
• 依托单位: UNIVERSITY OF PENNSYLVANIA
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-06-01 至 2022-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9977548
• 关键词: 3-Dimensional; Acute; Age; Aging; Cells; Chromatin; Chronic; Data; Diet; Disease; Enhancers; Ensure; Epigenetic Process; Fatty Liver; Fatty acid glycerol esters; Fibroblasts; Foundations; Future; Gene Expression; General Population; Genes; Genetic Enhancer Element; Genetic Transcription; Genome; Goals; Hepatocyte; Histone Acetylation; Human; Immune; Immunology; Inflammation; Inflammatory; Intervention; Knockout Mice; Light; Link; Liver; Liver diseases; Malignant Neoplasms; Maps; Mediating; Mentors; Metabolic; Metabolic Diseases; Metabolism; Modeling; Morbidity - disease rate; Mus; Oncogenic; Pathway interactions; Phase; Phenotype; Predisposition; Probability; Proliferating; Public Health; Regulation; Regulatory Pathway; Research; Secure; Signal Transduction; Source; Specificity; Stimulator of Interferon Genes; Stress; Structural Protein; Testing; Time; Tissues; Training; age related; career; career development; cell age; cell type; connectome; experience; functional decline; healthy aging; in vivo; insight; mortality; mouse model; new therapeutic target; non-alcoholic; normal aging; novel; programs; promoter; response; senescence; therapeutic target; transcription factor

PROJECT SUMMARY/ABSTRACT My overarching goal is to understand the three-dimensional (3D) enhancer regulation of aging and age-related diseases. Aging is accompanied by functional decline of tissues and an increased probability of many diseases. Epigenetic alteration is one hallmark of aging. Several lines of evidence demonstrate that histone acetylation levels elevate in senescent cells and global remodeling of the enhancer landscape occurs in aging and senescence. However, there is poor understanding of the influence of three-dimensional (3D) enhancer regulation changes during senescence. My preliminary data demonstrate that many enhancers connect together to form large clusters, termed hubs. The enhancers and promoters included in hubs are different between proliferation and senescence. The senescence-specific hubs ensure critical transcription programs for senescent phenotypes. However, how enhancer hubs change in response to stress and the mechanisms and functions of these alterations remain to be elucidated. The main goal of the proposed studies is to uncover mechanisms underlying the 3D regulation of enhancer hubs under different sources of stress during aging and age-related disease. I hypothesize that (1) during aging, key enhancers cluster together within hubs to regulate stress-specific gene expression programs; (2) two enhancer regulatory pathways exist during normal aging: one is cell intrinsic, and the other is cell extrinsic deriving from environmental inflammatory signals which accelerate the intrinsic pathway. In the mentored K99 phase (Aim 1), I will study epigenetic mechanisms regulating 3D enhancer hubs in senescence (Aim 1a) and test their generalization among different types of senescence (Aim 1b). Completion of these aims will set the stage for my independent research in aging and age-related metabolic disorder. In the R00 phase (Aim 2), in natural aging in liver, utilizing a unique mouse model, I will dissect the intrinsic enhancer regulatory pathway in hepatocytes and the extrinsic pathway stimulated by environmental inflammatory signals. This will provide potential targets to ameliorate age-related metabolic disorders in future direction of my independent lab. Ultimately, the proposed research will unveil new mechanisms underlying the interplay between inflammation and enhancer regulation in aging and provide novel therapeutic targets for age-related diseases. The career development and training components in K99 phase will expand my experience in aging, metabolism and immunology to provide a rich foundation for my successful transition to an independent career.

项目概要/摘要 我的首要目标是了解衰老和年龄相关的三维 (3D) 增强子调节 疾病。衰老伴随着组织功能衰退和许多疾病发生的可能性增加。 疾病。表观遗传改变是衰老的标志之一。多项证据表明组蛋白 衰老细胞中的乙酰化水平升高，并且在衰老过程中发生增强子景观的整体重塑 和衰老。然而，人们对三维（3D）增强剂的影响了解甚少 衰老过程中的调节变化。我的初步数据表明许多增强子连接 聚集在一起形成大型集群，称为枢纽。 hub中包含的增强子和启动子是不同的 增殖与衰老之间。衰老特异性中心确保关键的转录程序 衰老表型。然而，增强子中枢如何响应压力而变化以及机制和 这些改变的功能仍有待阐明。拟议研究的主要目标是揭示 不同压力源下增强子中枢3D调节的潜在机制 衰老和与年龄相关的疾病。我假设（1）在衰老过程中，关键增强子在内部聚集在一起 调节应激特异性基因表达程序的中心； (2) 存在两条增强子调控途径 正常衰老：一种是细胞内在的，另一种是环境炎症引起的细胞外源性的 加速内在途径的信号。在指导的 K99 阶段（目标 1），我将研究表观遗传学 衰老过程中调节 3D 增强子中枢的机制（目标 1a）并测试其在 不同类型的衰老（目标 1b）。完成这些目标将为我的独立奠定基础 衰老和与年龄相关的代谢紊乱的研究。在 R00 阶段（目标 2），在肝脏自然老化过程中， 利用独特的小鼠模型，我将剖析肝细胞中的内在增强子调节途径以及 环境炎症信号刺激的外在途径。这将提供潜在的目标 改善与年龄相关的代谢紊乱是我独立实验室未来的方向。最终，提议的 研究将揭示炎症与增强子调节之间相互作用的新机制 并为与年龄相关的疾病提供新的治疗靶点。职业发展和培训 K99相的成分将扩展我在衰老、代谢和免疫学方面的经验，为我提供丰富的经验。 为我成功过渡到独立职业奠定了基础。